| Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies ALM Williams, AM Baran, PJ Meacham, MM Feldman, HE Valencia, ... Leukemia & lymphoma 59 (3), 625-632, 2018 | 78 | 2018 |
| Management of melanoma in patients with chronic lymphocytic leukemia WJ Archibald, PJ Meacham, ALM Williams, AM Baran, AI Victor, PM Barr, ... Leukemia research 71, 43-46, 2018 | 22 | 2018 |
| Interval robotic cytoreduction following neoadjuvant chemotherapy in advanced ovarian cancer SA Ackroyd, S Thomas, C Angel, R Moore, PJ Meacham, B DuBeshter Journal of robotic surgery 12, 245-250, 2018 | 19 | 2018 |
| A phase 1/2 study of umbralisib ublituximab and venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) PM Barr, BT Hill, S Ma, AM Baran, A Bui, PJ Meacham, A Morrison, ... Blood 134, 360, 2019 | 17 | 2019 |
| Initial treatment of B‐cell prolymphocytic leukemia with ibrutinib J Moore, AM Baran, PJ Meacham, AG Evans, PM Barr, CS Zent American Journal of Hematology 95 (5), E108-E110, 2020 | 15 | 2020 |
| Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery D Mikdadi, KA O’Connell, PJ Meacham, MA Dugan, MO Ojiere, ... Cancer Biomarkers 33 (2), 173-184, 2022 | 13 | 2022 |
| Late relapses after high-dose chemotherapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in the rituximab era BD Hunter, M Herr, PJ Meacham, F Barlaskar, AG Evans, WR Burack, ... Clinical Lymphoma Myeloma and Leukemia 17 (3), 145-151, 2017 | 12 | 2017 |
| Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications SA Parikh, PJ Meacham, CS Zent, AG Evans Leukemia & Lymphoma 61 (5), 1037-1051, 2020 | 10 | 2020 |
| Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer B Moftakhar, M Lekkala, M Strawderman, TC Smith, P Meacham, ... Breast Cancer Research and Treatment 183, 411-418, 2020 | 9 | 2020 |
| The association between early-life relative telomere length and childhood neurodevelopment MO Feiler, D Patel, H Li, PJ Meacham, GE Watson, C Shamlaye, A Yeates, ... NeuroToxicology 65, 22-27, 2018 | 9 | 2018 |
| A phase 1/2 study of umbralisib, ublituximab, and venetoclax (U2-Ven) in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) PM Barr, S Ma, CS Zent, AM Baran, A Bui, PJ Meacham, A Morrison, ... Blood 136, 41-42, 2020 | 7 | 2020 |
| Ibrutinib therapy for lymphoplasmacytic lymphoma MJ Helber, JE Moore, ALM Williams, PJ Meacham, PG Rothberg, CS Zent American journal of hematology 92 (9), E542-E544, 2017 | 3 | 2017 |
| High risk of infections in chronic lymphocytic leukemia patients treated with B-cell receptor inhibitors AM Williams, AM Baran, PJ Meacham, M Herr, HE Valencia, C Newsom, ... Blood 128 (22), 3203, 2016 | 3 | 2016 |
| Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) PJ Meacham, ALM Williams, M Strawderman, AM Baran, WJ Archibald, ... Leukemia & lymphoma 61 (7), 1636-1644, 2020 | 2 | 2020 |
| Describing the learning curve for laparoscopic sentinel lymph node mapping for endometrial cancer MN Towner, KA Underkofler, PJ Meacham, C Angel, B DuBeshter, ... Gynecologic Oncology 159, 300-301, 2020 | 1 | 2020 |
| A novel method for identifying transgender and gender diverse patients with lymphoma: A single center experience AB Alpert, SA Nagle, MJ Greer, PJ Meacham, P Macdowell, N Gerbino, ... Blood 134, 5825, 2019 | 1 | 2019 |
| Characterization of patients with isolated tumor cells and micrometastasis on sentinel lymph node biopsy performed for endometrial cancer staging KA Underkofler, MN Towner, A Urh, PJ Meacham, KM Robison, ... Gynecologic Oncology 159, 47-48, 2020 | | 2020 |
| Relationship between body mass index, characteristics of sentinel lymph nodes, and disease features in women with endometrial cancer MN Towner, KA Underkofler, A Urh, PJ Meacham, KM Robison, ... Gynecologic Oncology 159, 219-220, 2020 | | 2020 |
| Impact of Progesterone Receptor (PR) and Androgen Receptor (AR) on Aromatase Inhibitor Treated Estrogen Receptor (ER) Positive Metastatic Breast Carcinomas X Wang, S Kadambi, L Eckert-Davis, M Strawderman, P Meacham, ... LABORATORY INVESTIGATION 100 (SUPPL 1), 281-281, 2020 | | 2020 |
| Morphologic Changes Associated with BTK Inhibitor Treatment Failure in CLL M Noor, J Kruger, P Meacham, C Zent, A Evans LABORATORY INVESTIGATION 100 (SUPPL 1), 1356-1356, 2020 | | 2020 |
